Teva, GSK Want Lamictal Suit Paused To Appeal Class Cert.
GlaxoSmithKline PLC and Teva Pharmaceutical Industries Ltd. are aiming to dismantle drug wholesalers' newly secured class certification in an antitrust battle centered on the availability of generic options to brand-name epilepsy...To view the full article, register now.
Already a subscriber? Click here to view full article